» Articles » PMID: 30785930

The Risk Factors for Diabetic Peripheral Neuropathy: A Meta-analysis

Overview
Journal PLoS One
Date 2019 Feb 21
PMID 30785930
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic peripheral neuropathy (DPN), the most common chronic complication of diabetes, has become an important public health crisis worldwide. Given that DPN is extremely difficult to treat, determining its risk factors and controlling it at an early stage is critical to preventing its serious consequences and the burden of social disease. Current studies suggest that the risk factors for diabetic peripheral neuropathy are the duration of diabetes, age, glycosylated hemoglobin A1c (HbA1c), diabetic retinopathy (DR), smoking, and body mass Index (BMI). However, most of the aforementioned studies are cross-sectional, and the sample sizes are very limited, so the strength of causal reasoning is relatively low. The current study systematically evaluated DPN's influencing factors in patients with type 2 diabetes using evidence-based medicine. Overall, 16 included studies (14 cross-sectional studies and 2 case-control studies including 12,116 cases) that conformed to the present criteria were included in the final analysis. The results suggested that the duration of diabetes (MD 2.5, 95% CI 1.71~3.29), age (MD 4.00, 95% CI 3.05~4.95), HbA1c (MD 0.48, 95% CI 0.33~0.64), and DR (OR 2.34, 95% CI 1.74~3.16) are associated with significantly increased risks of DPN among diabetic patients, while BMI, smoking, total triglyceride (TG), and total cholesterol (TC) did not indicate any risks of increasing DPN. The findings provide a scientific basis for a further understanding of the causes of type 2 diabetes complicated with peripheral neuropathy and the improvement of preventive strategies. The next step is to conduct further high-quality prospective cohort studies to validate this paper's findings.

Citing Articles

Intravenous streptozotocin induces variants in painful diabetic peripheral neuropathy in female mice.

Hagenimana M, Green A, Tierney J, Lenert M, Burton M Res Sq. 2025; .

PMID: 40034446 PMC: 11875293. DOI: 10.21203/rs.3.rs-6058617/v1.


Therapeutic effect of Chinese Tuina on diabetic peripheral neuropathy: systematic review and meta-analysis.

Yan H, Guan H, Sun J, Zhang S, Zhu H, Wang F Am J Transl Res. 2025; 17(1):499-511.

PMID: 39959234 PMC: 11826208. DOI: 10.62347/QAUW2551.


The role of activated partial thrombin time in mediating the impact of poorly glycemic control on diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.

Zhang H, Chen M, Sun L, Zhu W, Niu T, Fareeduddin Mohammmed Farooqui H Front Endocrinol (Lausanne). 2025; 16:1501323.

PMID: 39917541 PMC: 11798803. DOI: 10.3389/fendo.2025.1501323.


Nerve Conduction Study, Sympathetic Skin Response Test, and Demographic Correlates in Type 2 Diabetes Mellitus Patients.

Lee Y, Kim S, Kim C Ann Rehabil Med. 2025; 49(1):40-48.

PMID: 39910961 PMC: 11895056. DOI: 10.5535/arm.240042.


Causal relationships between plasma lipidome and diabetic neuropathy: a Mendelian randomization study.

Wang Z, Liu Z, Yang Q, Qiao H, Yin Y, Zhao Z Front Endocrinol (Lausanne). 2025; 15:1398691.

PMID: 39882262 PMC: 11774734. DOI: 10.3389/fendo.2024.1398691.


References
1.
Nie C, Bao H . [Analysis of the related risk factors of diabetic peripheral neuropathy]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013; 26(6):467-9. View

2.
Tesfaye S, Selvarajah D, Gandhi R, Greig M, Shillo P, Fang F . Diabetic peripheral neuropathy may not be as its name suggests: evidence from magnetic resonance imaging. Pain. 2016; 157 Suppl 1:S72-S80. DOI: 10.1097/j.pain.0000000000000465. View

3.
Callaghan B, Cheng H, Stables C, Smith A, Feldman E . Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012; 11(6):521-34. PMC: 4254767. DOI: 10.1016/S1474-4422(12)70065-0. View

4.
Morkrid K, Ali L, Hussain A . Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh. Int J Diabetes Dev Ctries. 2010; 30(1):11-7. PMC: 2859278. DOI: 10.4103/0973-3930.60004. View

5.
Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A . IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271-281. DOI: 10.1016/j.diabres.2018.02.023. View